The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul

Covid19 Clinical Trial

Official title:

The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04479124
• Other study ID #: KSSTHR—TPED
• Status: Completed
• Start date: March 10, 2020
• Est. completion date: July 14, 2020

Study information

• Verified date: July 2020
• Source: Kanuni Sultan Suleyman Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. The aim of this multi-centered study is to guide for the approach, organization, diagnosis and treatment of the patients admitted due to trauma to emergency department during the pandemic period.

Description:

COVID-19, which emerged in China in December 2019, has become a pandemic with its spread to many countries of the world. The investigators hypothesize that since the number of hospital applications expected to be decreased due to trauma during the COVID-19 period, the level of hospital trauma applications changed. Thus, the aim of this multi-centered study is to guide for the approach, organization, diagnosis and treatment of the patients admitted due to trauma to emergency department during the pandemic period.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2000
• Est. completion date: July 14, 2020
• Est. primary completion date: June 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A to 50 Years

Eligibility

Inclusion Criteria:

• accepted to participate with an informed consent

• trauma patients who admitted to the study centers

Exclusion Criteria:

• lack of informed consent

• lack of data

Related Conditions & MeSH terms

• Covid19
• Emergencies
• Trauma
• Wounds and Injuries

Intervention

Diagnostic Test:
• COVID-19 PCR
Nasopharyngeal samples were analyzed by PCR for the detection of Novel Coronavirus 2019 DNA

Locations

Country	Name	City	State
Turkey	Istanbul Kanuni Sultan Suleyman Training and Research Hospital	Istanbul	Kucukcekmece

Sponsors (1)

Lead Sponsor	Collaborator
Kanuni Sultan Suleyman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	trauma admissions	within the study period, trauma patients who admitted to any of the seven study centers will be recorded.	3 months